The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency
Cancers · 03.03.2023 · 15 (5) · 1590
DOI: 10.3390/cancers15051590 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 03.03.2023. Verfasst von Marta Santiago und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Department, Hospital La Fe, 46026 Valencia, Spain. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federación Española de Enfermedades Raras, Instituto de Salud Carlos III, Fundació La Marató de TV3.
Abstract (Originalsprache)
Hereditary myeloid malignancy syndromes (HMMSs) are rare but are becoming increasingly significant in clinical practice. One of the most well-known syndromes within this group is GATA2 deficiency. The GATA2 gene encodes a zinc finger transcription factor essential for normal hematopoiesis. Insufficient expression and function of this gene as a result of germinal mutations underlie distinct clinical presentations, including childhood myelodysplastic syndrome and acute myeloid leukemia, in which the acquisition of additional molecular somatic abnormalities can lead to variable outcomes. The only curative treatment for this syndrome is allogeneic hematopoietic stem cell transplantation, which should be performed before irreversible organ damage happens. In this review, we will examine the structural characteristics of the GATA2 gene, its physiological and pathological functions, how GATA2 genetic mutations contribute to myeloid neoplasms, and other potential clinical manifestations. Finally, we will provide an overview of current therapeutic options, including recent transplantation strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematology Department, Hospital La Fe, 46026 Valencia, Spain.
- Hematology Research Group, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.
- Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
- Genetics Unit, Hospital La Fe, 46026 Valencia, Spain.
ORCID-Profile: Alessandro Liquori, José Cervera
Förderung
- Federación Española de Enfermedades Raras
- Instituto de Salud Carlos III
- Fundació La Marató de TV3
- Generalitat Valenciana
- Asociación Española Contra el Cáncer
- FEDER
- Conselleria de Educación, Cultura y Deporte
- Rio Hortega
Zitieren
APA
Santiago, M., Liquori, A., Such, E., Zúñiga, Á., & Cervera, J. (2023). The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency. Cancers, 15(5), 1590. https://doi.org/10.3390/cancers15051590
Vancouver
Santiago M, Liquori A, Such E, Zúñiga Á, Cervera J. The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency. Cancers. 2023;15(5):1590. doi:10.3390/cancers15051590
BibTeX
@article{Santiago2023,
author = {Santiago, Marta and Liquori, Alessandro and Such, Esperanza and Zúñiga, Ángel and Cervera, José},
title = {The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency},
journal = {Cancers},
year = {2023},
volume = {15},
number = {5},
pages = {1590},
doi = {10.3390/cancers15051590}
}
EUVIMED